Similar findings are reported for patients with ALPS or DALD, who show increased levels of serum OPN and an increased risk of developing the diseases in subjects carrying the OPN haplotype B or haplotype C causing production of high levels of OPN. This evidence concerns the gene SPP1 and Dianzani autoimmune lymphoproliferative disease.